James Dudley Management

James Dudley Management

OTC Distribution in Europe

The New Global Agenda - New 2016 Edition

An in-depth strategic 20 country study of Europe’s
Major Markets

Table of Contents (PDF) Download This Report

OTC Distribution in Europe - the 2016 edition is an in-depth strategic analysis that defines and explores the main themes of change running through the European region and shows how they will influence consumer healthcare manufacturers’ channel strategies. It provides a wealth of knowledge covering 20 European markets together with statistics, analysis and insights into an increasingly complex market from a highly respected strategy consultant, James W. Dudley.

OTC Distribution in Europe covers: Austria, Belgium, Bulgaria, Czech Republic, Finland, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Slovak Republic, Slovenia, Spain, Sweden, Switzerland and the United Kingdom.

OTC Distribution in Europe is a study of the factors driving change and presenting challenges and opportunities to manufacturers. It includes analysis and discussion of European and national statutory and regulatory developments; healthcare supply chain economics; evolving formal and informal channel structures; distribution channel competitors’ market shares, linkages and groupings.

OTC Distribution in Europe is an exploration of changes in manufacturer, retail customer and shopper needs and the unfolding strategies required by healthcare companies to adapt and lead Europe's self-medication markets.

OTC Distribution in Europe provides insights and understanding of inter-channel rivalries between pharmacy and the mass market operators and the need for retail pharmacy chains or voluntary groups to force the pace of innovation. This is needed to challenge emerging competing channels including supermarkets, mail order pharmacies and the Internet.

OTC Distribution in Europe provides up-to-date statistics, insights, discussion and opinions regarding the historic, present and future challenges and opportunities for the European consumer healthcare market together with consumer insights, market sizes, sales trends and distributor market shares.

'OTC Distribution in Europe - the 2016 edition – the New Global Agenda, is the tenth edition of James W Dudley’s highly regarded consultancy study and marks the twentieth fifth year since the project began.

OTC Distribution in Europe – the New Global Agenda

Executive Sumary

A new and rapidly evolving competitive agenda is enveloping the supply networks which serve 473 million people living in 20 European countries with €29 billion worth of consumer health products.

Merger and acquisition activities are globalizing the supply chain and intensifying competitive pressures. Cross border mixed pharmacy chains are reshaping the consumer channel. Powerful retail brands employ digital technologies to drive multi-channel strategies and Internet pharmacies are undermining consumer prices.

Independent pharmacies are forming collectives, affiliated groupings and virtual chains in an attempt to remain competitive. Reducing government payments toward reimbursed prescription drugs and pressures on fees are forcing pharmacies to seek business from non price regulated consumer care ranges. Furthermore, deregulation of the non-prescription healthcare sector is shifting consumer demand to non-pharmacy channels in a number of countries.

OTC Distribution in Europe – the 2016 edition is a long running in-depth study that explores and tracks change. It identifies the driving factors coming into play which will influence the distribution channel environment for the consumer healthcare industry now and in the future. It provides a wealth of knowledge and comprehensive statistics and analysis covering 20 European countries, together with insights into an increasingly complex market sector from a highly respected strategy consultant, James W Dudley.

Among the main findings that will influence supplier strategies are:

  • Global aggregation of purchasing power, technology transfer and marketing synergies from mergers and strategic alliances between major North American and European retail and wholesale pharmacy companies
  • The development of multi-channel retail pharmacy brands driven by cross border retailers
  • Distributor strategies to expand economies of scale to invest in automation and new customer services thus increasing cost efficiencies and maximizing competitiveness
  • Continued reregulation of retail channels and the growth of mail order and cross-border Internet pharmacies
  • The growing importance of mixed estates of retail pharmacy groupings evolving into Europe-wide hybrid chains that overcome national restrictions on pharmacy ownership
  • The growth of affiliated groupings of independent pharmacies to compete in procurement and marketing
  • The development of digital technologies to reach out to multi-channel shoppers
  • Mass market retailers' ambitions to capture a share of the pharmacy market through products licensed for sale in non-pharmacy outlets and the acquisition of pharmacy licenses

These issues together will have a major influence on how manufacturers plan their strategies over the next few years.

Examples of findings of this new 20 country study from James Dudley are:

  • 85% of the consumer health market turnover passes through 145,143 pharmacies, while 15% is accessed through supermarkets, discounters, convenience stores, druggists and Internet and mail order pharmacies
  • 15% of European pharmacies are branches of wholly owned pharmacy multiples many of them international chains
  • One in three European pharmacies is a member of a 'virtual chain' or affiliated cooperation group of independent pharmacies
  • Internet pharmacies are playing an increasing role in consumers sources and choices of purchases for consumer healthcare and related products and services especially in Germany, the UK and Belgium
  • Nearly half of the intermediary pharmaceutical wholesale market is controlled by a handful of players

"In each new edition of OTC Distribution in Europe we discover new challenges or find old challenges that are changing shape. These will have positive or negative impacts on the business environment. Meeting these challenges and responding with effective plans will be a strategic necessity in the medium term. This means that all the stakeholders in the consumer healthcare sector need to explore the strategic opportunities and threats to find new factors for competitive success.

The aim of this 10th edition of OTC Distribution in Europe is to identify the challenges driving change and to provide thoughts on how to anticipate unfolding threats and seize opportunities"

James W Dudley - Author of OTC Distribution in Europe

Download the Table of Contents

We have made available the complete table of contents for this report in PDF format. You may download it for free.

Download Table of Contents (PDF)

Prices & Licences

Prices to suit organization and needs. Click here to buy.

License Type GBP £ Euros €* USD $*
Single User License1,8952,4652,845
Small Multi Use License (2 to 6 users)2,8453,6954,275
Corporate License5,685 7,3908,535

* Prices in Euros and USD are approximate, and subject to any conversion charges your bank may levy.

Buy OTC Distribution in Europe

Choose Licence

Choose Your Business Location

Secure Checkout

Accepted Payment Methods

  • Visa Card
  • Mastercard
  • American Express Card